Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-08-14
2007-08-14
Seaman, Margaret D. (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C544S127000, C544S333000
Reexamination Certificate
active
10555057
ABSTRACT:
The invention relates to compounds of the formula 1,in which the substituents and symbols have the meanings indicated in the description. The compounds are valuable intermediates for the preparation of pharmaceutical active compounds.
REFERENCES:
patent: 98/54188 (1998-12-01), None
patent: 01/72754 (2001-10-01), None
patent: 01/72755 (2001-10-01), None
patent: 01/72756 (2001-10-01), None
patent: 01/72757 (2001-10-01), None
patent: 02/34749 (2002-05-01), None
patent: 03/014120 (2003-02-01), None
patent: 03/014123 (2003-02-01), None
patent: 03/016310 (2003-02-01), None
Abe et al., J. med. Chem., “A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 1. Construction of the basic framework”, 1998, vol. 41, pp. 564-578.
“Information Update: vol. 1-25, No. 6”,Drugs of the Future 2001, vol. 26, No. 6, pp. 577-625, (2001).
Brehm Christof
Buhr Wilm
Altana Pharma AG
Goldberg Joshua B.
McGee Sheldon M.
Rahmani Niloofar
Seaman Margaret D.
LandOfFree
Imidazopyridine intermediates does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazopyridine intermediates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazopyridine intermediates will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3826991